Detalhe da pesquisa
1.
Anti-angiogenic therapy for ovarian cancer.
EJC Suppl
; 15: 77-86, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33240446
2.
Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer.
Int J Gynecol Cancer
; 29(6): 1050-1056, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31263024
3.
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study).
Clin Cancer Res
; 30(1): 176-186, 2024 01 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37527007
4.
Immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies, in a patient with melanoma treated with BRAF/MEK inhibitors.
Melanoma Res
; 32(4): 299-301, 2022 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35635528
5.
Prolonged Partial Response to Osimertinib after Disease Progression to Rociletinib in Metastasic EGFR T790M-Positive Non-Small Cell Lung Cancer.
J Thorac Oncol
; 13(5): e77-e79, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29703542